Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
International Journal of Hematology|July 24, 2021
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in AsiaYong-Pyo Lee, Sang Eun Yoon, Yuqin Song, et al.
Nature Communications|July 16, 2020
PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesisSlim Mzoughi, Jia Yi Fong, David Papadopoli, et al.
American Journal of Hematology|June 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell LymphomaAlyssa Bouska, Weiwei Zhang, Sunandini Sharma, et al.
The Journal of Clinical Investigation|January 2, 2025
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinomaYanni Zeng, Chun-Ling Luo, Guo-Wang Lin, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Leukemia|August 6, 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Leukemia|March 9, 2021
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
The Lancet. Oncology|December 28, 2019
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populationsGuo-Wang Lin, Caigang Xu, Kexin Chen, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
International Journal of Hematology|July 24, 2021
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in AsiaYong-Pyo Lee, Sang Eun Yoon, Yuqin Song, et al.
Nature Communications|July 16, 2020
PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesisSlim Mzoughi, Jia Yi Fong, David Papadopoli, et al.
American Journal of Hematology|June 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell LymphomaAlyssa Bouska, Weiwei Zhang, Sunandini Sharma, et al.
The Journal of Clinical Investigation|January 2, 2025
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinomaYanni Zeng, Chun-Ling Luo, Guo-Wang Lin, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Leukemia|August 6, 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Leukemia|March 9, 2021
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
The Lancet. Oncology|December 28, 2019
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populationsGuo-Wang Lin, Caigang Xu, Kexin Chen, et al.
Pageof 19